WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Short Interest Update

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) was the recipient of a significant decrease in short interest during the month of February. As of February 13th, there was short interest totaling 2,315 shares, a decrease of 53.6% from the January 29th total of 4,990 shares. Based on an average daily volume of 6,918 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 6,918 shares, the short-interest ratio is presently 0.3 days.

Analyst Ratings Changes

Separately, The Goldman Sachs Group raised WuXi AppTec to a “buy” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, WuXi AppTec currently has a consensus rating of “Buy”.

WuXi AppTec Stock Up 7.0%

Shares of WUXAY stock opened at $15.69 on Friday. WuXi AppTec has a 52-week low of $5.73 and a 52-week high of $16.35. The firm’s 50-day moving average is $14.45 and its 200-day moving average is $14.02.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.